|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,948.05 INR | +0.91% |
|
+3.83% | +28.80% |
| 09/07 | India's Dr Reddy's says semaglutide shipping disruption to last until at least late October | RE |
| 09/07 | India's Torrent Pharma recalls select semaglutide pens after Dr. Reddy's notice | RE |
Business description: Torrent Pharmaceuticals Limited
Number of employees: 18,258
Sales by Activity: Torrent Pharmaceuticals Limited
| Fiscal Period: March | 2022 (INR) | 2023 (INR) | 2024 (INR) | 2025 (INR) | 2026 (INR) |
|---|---|---|---|---|---|
Generic Formulation Business | 8.51TCr | 9.62TCr | 11TCr | 12TCr | 14TCr |
Geographical breakdown of sales: Torrent Pharmaceuticals Limited
| Fiscal Period: March | 2022 (INR) | 2023 (INR) | 2024 (INR) | 2025 (INR) | 2026 (INR) |
|---|---|---|---|---|---|
India | 4.68TCr | 5.37TCr | 6.11TCr | 6.79TCr | 8.16TCr |
Other Countries | 1.05TCr | 1.23TCr | 1.34TCr | 1.39TCr | 1.84TCr |
United States | 1.07TCr | 1.16TCr | 1.08TCr | 1.1TCr | 1.36TCr |
Brazil | 742.04Cr | 935.46Cr | 1.13TCr | 1.1TCr | 1.36TCr |
Germany | 966.31Cr | 927.69Cr | 1.07TCr | 1.14TCr | 1.25TCr |
Executive Committee: Torrent Pharmaceuticals Limited
| Manager | Title | Age | Since |
|---|---|---|---|
Aman Samir Mehta
CEO | Chief Executive Officer | 34 | 01/08/2025 |
Sudhir Menon
DFI | Director of Finance/CFO | - | 01/09/2018 |
Geena Malhotra
CTO | Chief Tech/Sci/R&D Officer | - | 01/02/2026 |
Hasmukh Patel
COO | Chief Operating Officer | - | - |
| Compliance Officer | - | 01/08/2022 |
Composition of the Board of Directors: Torrent Pharmaceuticals Limited
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 62 | 30/07/2014 | |
| Director/Board Member | 46 | 08/02/2018 | |
Nayantara Bali
BRD | Director/Board Member | 59 | 07/03/2019 |
| Director/Board Member | 58 | 29/07/2022 | |
Aman Samir Mehta
BRD | Director/Board Member | 34 | 01/08/2022 |
| Director/Board Member | 63 | 01/10/2023 | |
Jinal S. Mehta
CHM | Chairman | 43 | - |
Holdings: Torrent Pharmaceuticals Limited
| Name | Stocks | % | Valuation |
|---|---|---|---|
| 7,82,65,402 | 48.75% | 1 898 M $ |
Company details: Torrent Pharmaceuticals Limited
Torrent Pharmaceuticals Ltd.
Torrent House
380009, Ahmedabad
+91 79 2659 9000
http://www.torrentpharma.com
Group companies: Torrent Pharmaceuticals Limited
| Name | Category and Sector |
|---|---|
Torrent Pharma GmbH
 Torrent Pharma GmbH Miscellaneous Commercial ServicesCommercial Services Engages in research and development in the field of natural sciences, engineering, agricultural sciences & medicine |
Miscellaneous Commercial Services
|
Other Pharmaceuticals
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.91% | +3.83% | +49.35% | +156.52% | 1.74TCr | |
| -0.56% | -2.64% | +49.04% | +168.24% | 1,06000Cr | |
| +0.31% | -2.00% | +64.29% | +63.06% | 62TCr | |
| -0.03% | -5.01% | +28.86% | +83.73% | 44TCr | |
| -1.75% | -2.91% | +28.78% | +24.35% | 33TCr | |
| +0.24% | -2.61% | +29.46% | +46.50% | 28TCr | |
| -1.75% | -12.77% | +20.67% | +23.05% | 27TCr | |
| +0.67% | -0.76% | -26.10% | -37.25% | 22TCr | |
| -0.81% | -3.66% | +22.07% | +59.72% | 20TCr | |
| +1.21% | +0.10% | +19.85% | +72.03% | 16TCr | |
| Average | -0.04% | -2.71% | +28.63% | +65.99% | 35.91TCr | |
| Weighted average by Cap. | +0.02% | -3.07% | +36.33% | +83.34% |
Sector
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TORNTPHARM Stock
- Company Torrent Pharmaceuticals Limited
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition